Showing results (1861-1870 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|March 31, 2019
Clinically Integrated Molecular Diagnostics in Adenoid Cystic CarcinomaJulia Thierauf, Nisha Ramamurthy, Vickie Y Jo, et al.
The Oncologist|August 24, 2019
Phase I Pharmacokinetic Study of Niraparib in Chinese Patients with Epithelial Ovarian CancerJian Zhang, Hong Zheng, Yunong Gao, et al.
The Oncologist|August 25, 2019
Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive ValueFederica Miglietta, Gaia Griguolo, Valentina Guarneri, et al.
The Oncologist|August 29, 2019
1q21 Gain Combined with High-Risk Factors Is a Heterogeneous Prognostic Factor in Newly Diagnosed Multiple Myeloma: A Multicenter Study in ChinaXiaozhe Li, Wenming Chen, Yin Wu, et al.
The Oncologist|August 7, 2019
A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast CancerJennifer M Segar, Darien Reed, Alison Stopeck, et al.
The Oncologist|August 7, 2019
Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor TherapyMichael A Morse, Howard Hochster, Al Benson
The Oncologist|May 20, 2015
A Phase I Trial of Bortezomib and Sorafenib in Advanced Malignant MelanomaRyan J Sullivan, Nageatte Ibrahim, Donald P Lawrence, et al.
The Oncologist|May 13, 2015
Choice of Starting Dose for Biopharmaceuticals in First-in-Human Phase I Cancer Clinical TrialsAaron R Hansen, Natalie Cook, M Stacey Ricci, et al.
The Oncologist|May 8, 2015
BRCAPRO 6.0 Model Validation in Male Patients Presenting for BRCA TestingZahi I Mitri, Michelle Jackson, Carolyn Garby, et al.
The Oncologist|May 29, 2015
Treatment of Metastatic Breast Cancer in a Real-World Scenario: Is Progression-Free Survival With First Line Predictive of Benefit From Second and Later Lines?Marta Bonotto, Lorenzo Gerratana, Donatella Iacono, et al.
Pageof 571